Kenji Kashiwagi

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 36

Top Topics

Diabetic Retinopathy

Ejection Fraction

Top Venues

Journal of clinical medicine

Pharmaceuticals (Basel, Switzerland)

Journal of ophthalmology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Misa Kimura, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Yuka Kasai, Atsushi Sugiyama, Wataru Kikushima, Daphne Viel Tsuru, Kenji Kashiwagi
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Misa Kimura, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Yuka Kasai, Atsushi Sugiyama, Wataru Kikushima, Daphne Viel Tsuru, Kenji Kashiwagi
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Kenji Kashiwagi, Kentaro Ouchi, Yoshiyuki Shibasaki, Masaki Suginaka
Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions. Japanese journal of ophthalmology (2023)
Kazuyoshi Kitamura, Yoshiko Fukuda, Yuka Hasebe, Mio Matsubara, Kenji Kashiwagi
Mid-Term Results of Ab Interno Trabeculectomy among Japanese Glaucoma Patients. Journal of clinical medicine 12 (6) (2023)
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Atsushi Sugiyama, Kenji Kashiwagi
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Yumi Shigemoto, Yuka Hasebe, Kazuyoshi Kitamura, Yoshiko Fukuda, Masako Sakamoto, Mio Matsubara, Shinya Minaguchi, Kenji Kashiwagi
Repeated Measurements Are Necessary for Evaluating Accurate Diurnal Rhythm Using a Self-Intraocular Pressure Measurement Device. Journal of clinical medicine 12 (7) (2023)
Youichi Shinozaki, Kenji Kashiwagi, Schuichi Koizumi
Astrocyte Immune Functions and Glaucoma. International journal of molecular sciences 24 (3) (2023)
Natsuki Okabe, Airi Takahashi, Yumi Shigemoto, Chio Kogure, Tadao Ooka, Ryoji Shinohara, Sanae Otawa, Anna Kobayashi, Sayaka Horiuchi, Megumi Kushima, Zentaro Yamagata, Kenji Kashiwagi, null The Yamanashi Adjunct Study Of The Japan Environment And Children's Study Group
Refractive Error and Axial Length and Their Related Factors in 8-Year-Old Japanese Children: The Yamanashi Adjunct Study of the Japan Environment and Children's Study (JECS). Journal of clinical medicine 12 (18) (2023)
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Atsushi Sugiyama, Kenji Kashiwagi
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Youichi Shinozaki, Kenji Kashiwagi, Schuichi Koizumi
Astrocyte Immune Functions and Glaucoma. International journal of molecular sciences 24 (3) (2023)
Youichi Shinozaki, Kenji Kashiwagi, Schuichi Koizumi
Astrocyte Immune Functions and Glaucoma. International journal of molecular sciences 24 (3) (2023)
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Atsushi Sugiyama, Kenji Kashiwagi
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Atsushi Sugiyama, Kenji Kashiwagi
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Kazuyoshi Kitamura, Yoshiko Fukuda, Yuka Hasebe, Mio Matsubara, Kenji Kashiwagi
Mid-Term Results of Ab Interno Trabeculectomy among Japanese Glaucoma Patients. Journal of clinical medicine 12 (6) (2023)
Kazuyoshi Kitamura, Yoshiko Fukuda, Yuka Hasebe, Mio Matsubara, Kenji Kashiwagi
Mid-Term Results of Ab Interno Trabeculectomy among Japanese Glaucoma Patients. Journal of clinical medicine 12 (6) (2023)
Wataru Kikushima, Yoichi Sakurada, Kenji Kashiwagi
Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan. Journal of clinical medicine 11 (23) (2022)
Wataru Kikushima, Yoichi Sakurada, Kenji Kashiwagi
Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan. Journal of clinical medicine 11 (23) (2022)
Nao Aisu, Masahiro Miyake, Kohei Takeshita, Masato Akiyama, Ryo Kawasaki, Kenji Kashiwagi, Taiji Sakamoto, Tetsuro Oshika, Akitaka Tsujikawa
Regulatory-approved deep learning/machine learning-based medical devices in Japan as of 2020: A systematic review. PLOS digital health 1 (1) (2022)
Nao Aisu, Masahiro Miyake, Kohei Takeshita, Masato Akiyama, Ryo Kawasaki, Kenji Kashiwagi, Taiji Sakamoto, Tetsuro Oshika, Akitaka Tsujikawa
Regulatory-approved deep learning/machine learning-based medical devices in Japan as of 2020: A systematic review. PLOS digital health 1 (1) (2022)
Wataru Kikushima, Yoichi Sakurada, Kenji Kashiwagi
Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan. Journal of clinical medicine 11 (23) (2022)
Youichi Shinozaki, Alex Leung, Kazuhiko Namekata, Sei Saitoh, Huy Bang Nguyen, Akiko Takeda, Yosuke Danjo, Yosuke M Morizawa, Eiji Shigetomi, Fumikazu Sano, Nozomu Yoshioka, Hirohide Takebayashi, Nobuhiko Ohno, Takahiro Segawa, Kunio Miyake, Kenji Kashiwagi, Takayuki Harada, Shin-Ichi Ohnuma, Schuichi Koizumi
Astrocytic dysfunction induced by ABCA1 deficiency causes optic neuropathy. Science advances 8 (44) (2022)
Wataru Kikushima, Taiyo Shijo, Yukiko Furuhata, Yoichi Sakurada, Kenji Kashiwagi
Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Yoshiko Fukuda, Yoichi Sakurada, Mio Matsubara, Yuka Hasebe, Atsushi Sugiyama, Wataru Kikushima, Kenji Kashiwagi
Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy. Biomedicines 9 (9) (2021)
Taiyo Shijo, Yoichi Sakurada, Koji Tanaka, Akiko Miki, Seigo Yoneyama, Yumiko Machida, Aya Chubachi, Yu Wakatsuki, Atsushi Sugiyama, Hajime Onoe, Wataru Kikushima, Ryusaburo Mori, Kenji Kashiwagi
Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics. International journal of molecular sciences 22 (8) (2021)
Wataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, Seigo Yoneyama, Mio Matsubara, Yoshiko Fukuda, Kenji Kashiwagi
Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity. Journal of clinical medicine 10 (5) (2021)
Kenji Kashiwagi, Yuji Matsuda, Yuka Ito, Hisami Kawate, Masako Sakamoto, Shinji Obi, Hirotaka Haro
Investigation of visual and physical factors associated with inadequate instillation of eyedrops among patients with glaucoma. PloS one 16 (5) (2021)
Kenji Kashiwagi, Eriko Chono, Sarah Koesters, Poh Sin Yap
Persistence and treatment patterns of fixed combination drugs for glaucoma: a retrospective claims database study in Japan. BMC ophthalmology 20 (1) (2020)
Mio Matsubara, Yoichi Sakurada, Atsushi Sugiyama, Yoshiko Fukuda, Ravi Parikh, Kenji Kashiwagi
Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results. PloS one 15 (8) (2020)
Atsuki Kume, Kenji Kashiwagi
Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus. BMC ophthalmology 20 (1) (2020)
Taiyo Shijo, Yoichi Sakurada, Seigo Yoneyama, Wataru Kikushima, Atsushi Sugiyama, Mio Matsubara, Yoshiko Fukuda, Fumihiko Mabuchi, Kenji Kashiwagi
Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration. Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)
Kenji Kashiwagi
Wide Variation of Squeezing Force and Dispensing Time Interval among Eyedropper Bottles. Journal of ophthalmology 2019 (2019)
Kenji Kashiwagi, Mio Matsubara
Reduction in Ocular Hypotensive Eyedrops by Ab Interno Trabeculotomy Improves Not Only Ocular Surface Condition But Also Quality of Vision. Journal of ophthalmology 2018 (2018)
Kazuyoshi Kitamura, Tatsuya Chiba, Fumihiko Mabuchi, Kiyotaka Ishijima, Shu Omoto, Fumiko Kashiwagi, Takashi Godo, Satoshi Kogure, Teruhiko Goto, Takashi Shibuya, Jhoji Tanabe, Shigeo Tsukahara, Tadaharu Tsuchiya, Toyoaki Tsumura, Takaharu Tokunaga, Osamu Hosaka, Tetsunori Saito, Kenji Kashiwagi
Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy. Journal of ophthalmology 2018 (2018)
Toshie Furuya, Kenji Kashiwagi
Longitudinal Change in Peripheral Anterior Chamber Depth of Eyes with Angle Closure after Laser Iridotomy. Journal of ophthalmology 2018 (2018)
Masako Sakamoto, Kazuyoshi Kitamura, Kenji Kashiwagi
Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database. Journal of ophthalmology 2017 (2017)
Hiroshi Yokomichi, Kenji Kashiwagi, Kazuyoshi Kitamura, Yoshioki Yoda, Masahiro Tsuji, Mie Mochizuki, Miri Sato, Ryoji Shinohara, Sonoko Mizorogi, Kohta Suzuki, Zentaro Yamagata
Evaluation of the associations between changes in intraocular pressure and metabolic syndrome parameters: a retrospective cohort study in Japan. BMJ open 6 (3) (2016)